Monsters of Rock: Crazy US government rare earths deal puts rocket under sector
Lunch Wrap: Resources the only bright spot as ASX stumbles
Super funds finally bank some anti-hacker advice
Ten Bagger: Manganese back on the menu as investors feast on Black Canyon
Top 10 at 11: ASX pulls back from early gains; ASX biotechs go global
AI chatbots are ‘poisoning data’, regulator warns universities
Mooners and Shakers: It’s big, it’s beautiful… it’s orange. Bitcoin smashes to new high
Winners and Losers: Nigel Green’s mid-year global market outlook
Go West for chardonnay created by earth, wind and … gum trees
New Prescient leadership to drive PTX-100 development in rare blood cancer
Contributors
Our Resident Experts
Mining
Ten Bagger: Manganese back on the menu as investors feast on Black Canyon
Resources Top 5: Chariot races to the front in new African lithium hot spot
The ASX explorers preparing to drill baby, drill in the land of opportunity
Trump tariff threat sends US copper price soaring – how will it impact miners?
Why Brazil’s rare earth deposits could catch major attention
Featured in Mining
Tech
Health & Biotech
Suffering from news overwhelm? Here are three tips to protect your peace
Health Check: For ASX biotechs, the business of America remains business
Health Check: POTUS puts drug tariffs back on agenda… another case of TACO?
Health Kick Podcast: Neurizon’s ALS push and trial plans
ASX biotechs join global race for cell therapy breakthroughs
Featured in Health & Biotech
Experts
Five ways to make interest rates work harder for you
The winners and losers from new superannuation rules
Are ETFs behind Commonwealth Bank’s record run?
ASX Trader: Why the next market crash might already be on the calendar
AI is reshaping investment portfolios
Criterion: Buy, hold or sell CBA? Investors face their NFY resolution
Stock Tips: An iron giant and a biotech behemoth make their presence felt
